Alveolar soft part sarcoma: a rare and enigmatic entity

Area of Science:

• Oncology
• Rare Cancers

Background:

• Alveolar soft part sarcoma (ASPS) is a rare malignancy with challenging clinical behavior.
• Evaluating ASPS treatment is difficult due to limited case numbers.
• Historically, primary tumor treatment is often successful, while metastatic disease treatment is less effective.

Purpose of the Study:

• To review treatment outcomes for primary and metastatic alveolar soft part sarcoma.
• To evaluate the effectiveness of current therapeutic approaches in ASPS patients.
• To identify areas for improvement in ASPS management, particularly for metastatic disease.

Main Methods:

• Retrospective review of 15 patients with alveolar soft part sarcoma.
• Analysis of treatment modalities including surgical excision, radiation, and chemotherapy.
• Assessment of outcomes for primary tumor control and metastatic disease progression.

Main Results:

• Nine of 15 patients presented with or developed metastatic disease.
• Primary tumors showed good local control with surgery and radiation; no local recurrences were observed.
• All instances of metastatic disease recurred or progressed despite chemotherapy, metastectomy, or radiation.
• Overall survival rates were 75% at 5 years and 40% at 10 years.

Conclusions:

• Current treatments achieve good local control of primary alveolar soft part sarcoma.
• Effective control of metastatic alveolar soft part sarcoma remains a significant challenge.
• Novel therapeutic strategies must be developed and applied to address metastatic ASPS.